Quamed would like to congratulate the ARP in Senegal and the RFDA in Rwanda on this major achievement. We have seen firsthand how hard they have worked and how much they have accomplished over the past years. Another milestone achieved related to increased access to quality medicines! https://www.who.int/news/item/05-12-2024-senegal-and-rwanda-achieve-who-maturity-level-3-in-medicines-regulation
We are delighted to announce that our “Implementing the WHO GSDP and MQAS Guidelines” course has been awarded the FIP Seal. You can read about our courses on the International Pharmaceutical Federation (FIP) microsite here. The course is accessible on the QUAMED Learning Platform (learning.quamed.org). The course will expand your expertise on pharmaceutical quality assurance. ...
Quamed launched its Quality Certification Programme (QCP) in early 2023, generating significant interest across the sector. To date, 63 organizations have expressed interest in pursuing QCP certification, with 32 submitting formal applications. Eight organizations have successfully obtained QCP certificates, while six more are progressing through the certification process. These numbers reflect both strong market interest ...
The World Health Organization (WHO) has issued an urgent alert about falsified OZEMPIC (semaglutide) detected in Brazil, the UK, and the USA. These counterfeit products pose significant health risks, including ineffective treatment and potential contamination. Identified batches include LP6F832, NAR0074 with serial number 430834149057, and falsified versions of genuine batch MP5E511. The public is advised ...
We would like to congratulate the MCAZ on becoming the 6th country in Africa to achieve WHO maturity level 3. We are indirectly profiting from their expertise as our colleague Linda Mudyiwenyama was part of the MCAZ team up to two years ago. Linda is currently collaborating with the Rwanda FDA in their quest to ...
QUAMED (www.quamed.org) is a not-for-profit organisation specialising in various aspects of pharmaceutical quality assurance. We conduct pharmaceutical assessments and audits, develop and facilitate training courses around pharmaceutical quality, auditing and inspection and organise and provide technical assistance in the field of pharmaceutical quality assurance. We are starting a new project in Senegal with as objective ...
On Monday 20th of May 2024, the WHO approved 33 national and regional regulatory authorities, including the U.S. FDA and the European Medicines Regulatory Network (EMRN), as WHO Listed Authorities (WLAs), bringing the total to 36 WLAs from 34 Member States since March 2022. This milestone enhances global cooperation and regulatory standards for medicine and vaccine ...
Attention healthcare professionals and regulatory authorities! Falsified (contaminated) USP/EP PROPYLENE GLYCOL has been detected in the WHO Eastern Mediterranean Region, specifically in Pakistan. The contaminated raw materials, not manufactured or supplied by DOW as confirmed, contain dangerously high levels of ethylene glycol, posing a severe health risk, particularly to children. Ethylene glycol ingestion can lead ...
WHO has released the “WHO List of Medically Important Antimicrobials (MIA)” as a crucial tool to combat antimicrobial resistance (AMR) from non-human use. This guidance supports decision-making for authorities, veterinarians, and agricultural professionals to minimize AMR impact. The MIA categorizes antimicrobials by importance to human medicine, including those authorized exclusively for human use like plazomicin ...
The WHO’s virtual Fair Pricing Forum from February 6th to 8th, 2024, focused on equitable access to essential medicines. Stakeholders, including Member States and private sectors, discussed enhancing market transparency and strategies for affordable healthcare. Despite invitation-only participation, the forum emphasized collaboration in addressing global health access challenges. To read more
Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.
En poursuivant votre visite sur ce site, vous acceptez l'utilisation de cookies En savoir plus
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.